NS-018 maleate is an inhibitor of JAK and Src-Family kinase potentially for the treatment of myelofibrosis References: Verstovsek S, Talpaz M, Ritchie E, Wadleigh M, Odenike O, Jamieson C, Stein B, Uno T, Mesa RA. A phase I, open-label, dose-escalation, multicenter study of the JAK2 inhibitor NS-018 in patients with myelofibrosis. Leukemia. 2017 Feb;31(2):393-402. doi: 10.1038/leu.2016.215. PubMed PMID: 27479177; PubMed Central PMCID: PMC5292677.

纯度：≥98%

CAS：1354799-87-3